Autores: Nugent Rachel, Okeke Iruka N
Despite tireless efforts to increase access to drugs in developing countries, we are losing our ability to cure common diseases because of the work of an invisible adversary: the drug resistant bug. Drug resistance is on the rise worldwide—not only because of the natural, evolutionary process that occurs as microbes adapt in the presence of drug therapy, but also because humans are hastening resistance, including through inappropriate use of medicines. Without a concerted global effort to ensure both broad access to drugs and lasting effectiveness of treatment, drug resistance will continue to cost lives, increase the cost of curing patients, and render future generations vulnerable to diseases as they rely on a shrinking collection of medicines that work.
Palabras clave: .
2011-04-21 | 375 visitas | Evalua este artículo 0 valoraciones
Vol. 4 Núm.6. Junio 2010 Pags. 355-356. J Infect Developing Countries 2010; 4(6)